The Helical virtual AI lab for pharma, an application layer that turns biological foundation models into decision-ready, reproducible in-silico discovery workflows. The $10 million funding will ...
VICTORIA, British Columbia--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”) today introduced a transformative AI-driven rapid therapeutic screening platform, the ...
In this Point of View column,, CEO of Taconic Biosciences, explores redefining preclinical models for the future of drug development.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results